Clinical Trial Update: Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating donor umbilical cord blood transplant with or without ex-vivo expanded cord blood progenitor cells in patients with acute and chronic l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia in Remission
• Acute Myeloid Leukemia in Remission
• Biphenotypic Leukemia
• Myelodysplastic Syndrome
• Myelogenous Leukemia

Snippet

Sponsor: Nohla Therapeutics, Inc. | Conditions: Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission | Phase 2 | Status: COMPLETED | Results posted: 2021-07-06